A Randomized Phase III Study of Definitive Radiation Therapy with or without Hydroxyurea in Previously Untreated Limited Unresectable Non-Small Cell Lung Cancer

Abstracts/Posters/Presentations:

• Mantravadi R, Sandler A, Montebello J, Ansari R, McClean J, Nattam S, Walker P, Einhorn L. Randomized Phase III Study of Cisplatin (P) and Vinblastine (V) Followed by Thoracic Radiotherapy With or Without Hydroxyurea (HX) In Previously Untreated Limited Unresectable Non-Small Cell Lung Cancer (NSCLC). A Hoosier Oncology Group and Walther Cancer Institute Trial LUN91-1. Accepted to the ASCO annual meeting May 16-19, 1998, Los Angeles, CA.
• Mantravadi R, Sandler A, Montebello J, Ansari R, Nattam S, McClean J, Walker P, Einhorn L. A Phase III Hoosier Oncology Group Study of Thoracic Radiotherapy (TRT) Plus Cisplatin (P) and Vinblastin (V) With or Without Hydroxyurea (HX) for Locally Unresectable Non-Small Cell Lung Cancer (NSCLC). Hoosier Oncology Group and Walther Cancer Institute Trial LUN91-1. Accepted at the ASTRO annual meeting October 25-28 1998, Phoenix, AZ